{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T14:18:36Z","timestamp":1780669116128,"version":"3.54.1"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med Inform Decis Mak"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>This study aimed to compare clinical and laboratory characteristics of supra-therapeutic (RSTI) and acute acetaminophen exposures using a predictive decision tree (DT) algorithm.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>We conducted a retrospective cohort study using the National Poison Data System (NPDS). All patients with RSTI acetaminophen exposure (n\u2009=\u20094,522) between January 2012 and December 2017 were included. Additionally, 4,522 randomly selected acute acetaminophen ingestion cases were included. After that, the DT machine learning algorithm was applied to differentiate acute acetaminophen exposure from supratherapeutic exposures.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>The DT model had accuracy, precision, recall, and F1-scores of 0.75, respectively. Age was the most relevant variable in predicting the type of acetaminophen exposure, whether RSTI or acute. Serum aminotransferase concentrations, abdominal pain, drowsiness\/lethargy, and nausea\/vomiting were the other most important factors distinguishing between RST and acute acetaminophen exposure.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>DT models can potentially aid in distinguishing between acute and RSTI of acetaminophen. Further validation is needed to assess the clinical utility of this model.<\/jats:p><\/jats:sec>","DOI":"10.1186\/s12911-023-02188-2","type":"journal-article","created":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T11:02:54Z","timestamp":1685617374000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Using a decision tree algorithm to distinguish between repeated supra-therapeutic and acute acetaminophen exposures"],"prefix":"10.1186","volume":"23","author":[{"given":"Omid","family":"Mehrpour","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Hoyte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samaneh","family":"Nakhaee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno","family":"Megarbane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Foster","family":"Goss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,6,1]]},"reference":[{"issue":"9","key":"2188_CR1","doi-asserted-by":"publisher","first-page":"2174","DOI":"10.1007\/s11095-013-1007-6","volume":"30","author":"MR McGill","year":"2013","unstructured":"McGill MR, Jaeschke H. Metabolism and disposition of acetaminophen: recent advances in relation to hepatotoxicity and diagnosis. Pharm Res. 2013;30(9):2174\u201387.","journal-title":"Pharm Res"},{"issue":"1","key":"2188_CR2","doi-asserted-by":"publisher","first-page":"19","DOI":"10.3949\/ccjm.77a.09084","volume":"77","author":"A Schilling","year":"2010","unstructured":"Schilling A, Corey R, Leonard M, et al. Acetaminophen: old drug, new warnings. Cleve Clin J Med. 2010;77(1):19\u201327.","journal-title":"Cleve Clin J Med"},{"issue":"2","key":"2188_CR3","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1007\/s00204-014-1432-2","volume":"89","author":"EM Lancaster","year":"2015","unstructured":"Lancaster EM, Hiatt JR, Zarrinpar A. Acetaminophen hepatotoxicity: an updated review. Arch Toxicol. 2015;89(2):193\u20139.","journal-title":"Arch Toxicol"},{"issue":"6","key":"2188_CR4","doi-asserted-by":"publisher","first-page":"1364","DOI":"10.1002\/hep.20948","volume":"42","author":"AM Larson","year":"2005","unstructured":"Larson AM, Polson J, Fontana RJ, et al. Acetaminophen-induced acute liver failure: results of a United States multicenter, prospective study. Hepatology. 2005;42(6):1364\u201372.","journal-title":"Hepatology"},{"issue":"4","key":"2188_CR5","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1016\/j.cld.2013.07.005","volume":"17","author":"C Bunchorntavakul","year":"2013","unstructured":"Bunchorntavakul C, Reddy KR. Acetaminophen-related hepatotoxicity. Clin Liver Dis. 2013;17(4):587\u2013607.","journal-title":"Clin Liver Dis"},{"issue":"1","key":"2188_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/15563650500394571","volume":"44","author":"RC Dart","year":"2006","unstructured":"Dart RC, Erdman AR, Olson KR, et al. Acetaminophen poisoning: an evidence-based consensus guideline for out-of-hospital management. Clin Toxicol. 2006;44(1):1\u201318.","journal-title":"Clin Toxicol"},{"key":"2188_CR7","unstructured":"Bond G, Caravati E, Dart R et al. Guidelines for the Management of Acetaminophen Overdose. available at: https:\/\/www.tylenolprofessional.com\/sites\/tylenol_hcp_us\/files\/acetaminphen_overdose_treatment_info.pdf. 2015."},{"issue":"8","key":"2188_CR8","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1080\/15563650.2018.1547829","volume":"57","author":"H Egan","year":"2019","unstructured":"Egan H, Isbister GK, Robinson J, et al. Retrospective evaluation of repeated supratherapeutic ingestion (RSTI) of paracetamol. Clin Toxicol. 2019;57(8):703\u201311.","journal-title":"Clin Toxicol"},{"issue":"5","key":"2188_CR9","doi-asserted-by":"publisher","first-page":"215","DOI":"10.5694\/mja15.00614","volume":"203","author":"AL Chiew","year":"2015","unstructured":"Chiew AL, Fountain JS, Graudins A, et al. Summary statement: new guidelines for the management of paracetamol poisoning in Australia and New Zealand. Med J Aust. 2015;203(5):215\u20138.","journal-title":"Med J Aust"},{"issue":"4","key":"2188_CR10","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1016\/j.annemergmed.2004.05.005","volume":"44","author":"FF Daly","year":"2004","unstructured":"Daly FF, O\u2019Malley GF, Heard K, et al. Prospective evaluation of repeated supratherapeutic acetaminophen (paracetamol) ingestion. Ann Emerg Med. 2004;44(4):393\u20138.","journal-title":"Ann Emerg Med"},{"issue":"3","key":"2188_CR11","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1080\/15563650.2017.1359620","volume":"56","author":"A Wong","year":"2018","unstructured":"Wong A, Gunja N, McNulty R, et al. Analysis of an 8-hour acetylcysteine infusion protocol for repeated supratherapeutic ingestion (RSTI) of paracetamol. Clin Toxicol. 2018;56(3):199\u2013203.","journal-title":"Clin Toxicol"},{"key":"2188_CR12","doi-asserted-by":"publisher","first-page":"103185","DOI":"10.1016\/j.jbi.2019.103185","volume":"94","author":"J Badger","year":"2019","unstructured":"Badger J, LaRose E, Mayer J, et al. Machine learning for phenotyping opioid overdose events. J Biomed Inform. 2019;94:103185.","journal-title":"J Biomed Inform"},{"issue":"1","key":"2188_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12874-019-0681-4","volume":"19","author":"JA Sidey-Gibbons","year":"2019","unstructured":"Sidey-Gibbons JA, Sidey-Gibbons CJ. Machine learning in medicine: a practical introduction. BMC Med Res Methodol. 2019;19(1):1\u201318.","journal-title":"BMC Med Res Methodol"},{"issue":"20","key":"2188_CR14","doi-asserted-by":"publisher","first-page":"1920","DOI":"10.1161\/CIRCULATIONAHA.115.001593","volume":"132","author":"RC Deo","year":"2015","unstructured":"Deo RC. Machine learning in medicine. Circulation. 2015;132(20):1920\u201330.","journal-title":"Circulation"},{"key":"2188_CR15","first-page":"1","volume":"26","author":"A Amirabadizadeh","year":"2020","unstructured":"Amirabadizadeh A, Nakhaee S, Mehrpour O. Risk assessment of elevated blood lead concentrations in the adult population using a decision tree approach. Jun. 2020;26:1\u20138.","journal-title":"Jun"},{"issue":"12","key":"2188_CR16","doi-asserted-by":"publisher","first-page":"e013336","DOI":"10.1136\/bmjopen-2016-013336","volume":"6","author":"A Ramezankhani","year":"2016","unstructured":"Ramezankhani A, Hadavandi E, Pournik O, et al. Decision tree-based modelling for identification of potential interactions between type 2 diabetes risk factors: a decade follow-up in a Middle East prospective cohort study. BMJ open. 2016;6(12):e013336.","journal-title":"BMJ open"},{"issue":"5","key":"2188_CR17","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1023\/A:1016409317640","volume":"26","author":"V Podgorelec","year":"2002","unstructured":"Podgorelec V, Kokol P, Stiglic B, et al. Decision trees: an overview and their use in medicine. J Med Syst. 2002;26(5):445\u201363.","journal-title":"J Med Syst"},{"key":"2188_CR18","doi-asserted-by":"crossref","unstructured":"Mehrpour O, Hoyte C, Goss F et al. Decision tree algorithm can determine the outcome of repeated supratherapeutic ingestion (RSTI) exposure to acetaminophen: review of 4500 national poison data system cases. Drug Chem Toxicol. 2022:1\u20137.","DOI":"10.1080\/01480545.2022.2083149"},{"issue":"4","key":"2188_CR19","doi-asserted-by":"publisher","first-page":"58","DOI":"10.3390\/toxics6040058","volume":"6","author":"D Castanares-Zapatero","year":"2018","unstructured":"Castanares-Zapatero D, Dinant V, Ruggiano I, et al. Pattern of paracetamol poisoning: influence on outcome and complications. Toxics. 2018;6(4):58.","journal-title":"Toxics"},{"issue":"1","key":"2188_CR20","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1007\/s00580-017-2580-6","volume":"27","author":"M Tayefi","year":"2018","unstructured":"Tayefi M, Saberi-Karimian M, Esmaeili H, et al. Evaluating of associated risk factors of metabolic syndrome by using decision tree. Comp Clin Pathol. 2018;27(1):215\u201323.","journal-title":"Comp Clin Pathol"},{"issue":"2","key":"2188_CR21","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1111\/j.1365-2125.2011.04067.x","volume":"73","author":"DG Craig","year":"2012","unstructured":"Craig DG, Bates CM, Davidson JS, et al. Staggered overdose pattern and delay to hospital presentation are associated with adverse outcomes following paracetamol-induced hepatotoxicity. Br J Clin Pharmacol. 2012;73(2):285\u201394.","journal-title":"Br J Clin Pharmacol"},{"issue":"2","key":"2188_CR22","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1016\/S0022-3476(97)70359-7","volume":"130","author":"T Rivera-Penera","year":"1997","unstructured":"Rivera-Penera T, Gugig R, Davis J, et al. Outcome of acetaminophen overdose in pediatric patients and factors contributing to hepatotoxicity. J Pediatr. 1997;130(2):300\u20134.","journal-title":"J Pediatr"},{"issue":"2","key":"2188_CR23","doi-asserted-by":"publisher","first-page":"108","DOI":"10.3109\/15563650.2011.554839","volume":"49","author":"MA Alhelail","year":"2011","unstructured":"Alhelail MA, Hoppe JA, Rhyee SH, et al. Clinical course of repeated supratherapeutic ingestion of acetaminophen. Clin Toxicol. 2011;49(2):108\u201312.","journal-title":"Clin Toxicol"},{"issue":"954","key":"2188_CR24","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1136\/pgmj.2004.024794","volume":"81","author":"S Greene","year":"2005","unstructured":"Greene S, Dargan PI, Jones AL. Acute poisoning: understanding 90% of cases in a nutshell. Postgrad Med J. 2005;81(954):204\u201316.","journal-title":"Postgrad Med J"},{"issue":"3","key":"2188_CR25","doi-asserted-by":"publisher","first-page":"441","DOI":"10.2215\/CJN.01411005","volume":"1","author":"AZ Fenves","year":"2006","unstructured":"Fenves AZ, Kirkpatrick HM, Patel VV, et al. Increased anion gap metabolic acidosis as a result of 5-oxoproline (pyroglutamic acid): a role for acetaminophen. Clin J Am Soc Nephrol. 2006;1(3):441\u20137.","journal-title":"Clin J Am Soc Nephrol"},{"issue":"2","key":"2188_CR26","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1007\/s40199-019-00307-x","volume":"27","author":"F KhabazianZadeh","year":"2019","unstructured":"KhabazianZadeh F, Kazemi T, Nakhaee S, et al. Acetaminophen poisoning-induced heart injury: a case-based review. DARU J Pharm Sci. 2019;27(2):839\u201351.","journal-title":"DARU J Pharm Sci"},{"issue":"1","key":"2188_CR27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s40360-016-0073-x","volume":"17","author":"U Ralapanawa","year":"2016","unstructured":"Ralapanawa U, Jayawickreme KP, Ekanayake EMM, et al. A study on paracetamol cardiotoxicity. BMC Pharmacol Toxicol. 2016;17(1):1\u20138.","journal-title":"BMC Pharmacol Toxicol"},{"issue":"5","key":"2188_CR28","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1097\/01.CCN.0000578816.14164.9f","volume":"14","author":"SJ Saccomano","year":"2019","unstructured":"Saccomano SJ. Acute acetaminophen toxicity in adults. Nursing2020 Crit Care. 2019;14(5):10\u20137.","journal-title":"Nursing2020 Crit Care"},{"issue":"2","key":"2188_CR29","first-page":"131","volume":"4","author":"E Yoon","year":"2016","unstructured":"Yoon E, Babar A, Choudhary M, et al. Acetaminophen-induced hepatotoxicity: a comprehensive update. J Clin translational Hepatol. 2016;4(2):131.","journal-title":"J Clin translational Hepatol"},{"issue":"6","key":"2188_CR30","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1097\/00006565-199212000-00010","volume":"8","author":"JD Tobias","year":"1992","unstructured":"Tobias JD, Gregory DF, Deshpande JK. Ondansetron to prevent emesis following N-acetylcysteine for acetaminophen intoxication. Pediatr Emerg Care. 1992;8(6):345\u20136.","journal-title":"Pediatr Emerg Care"},{"issue":"2","key":"2188_CR31","first-page":"163","volume":"34","author":"RF Clark","year":"1996","unstructured":"Clark RF, Chen R, Williams SR, et al. The use of ondansetron in the treatment of nausea and vomiting associated with acetaminophen poisoning. J Toxicology: Clin Toxicol. 1996;34(2):163\u20137.","journal-title":"J Toxicology: Clin Toxicol"},{"issue":"1\u20132","key":"2188_CR32","first-page":"19","volume":"36","author":"EJ Scharman","year":"1998","unstructured":"Scharman EJ. Use of ondansetron and other antiemetics in the management of toxic acetaminophen ingestions. J Toxicology: Clin Toxicol. 1998;36(1\u20132):19\u201325.","journal-title":"J Toxicology: Clin Toxicol"},{"issue":"1","key":"2188_CR33","first-page":"35","volume":"37","author":"RO Wright","year":"1999","unstructured":"Wright RO, Wright R, Anderson AC, et al. Effect of metoclopramide dose on preventing emesis after oral administration of N-acetylcysteine for acetaminophen overdose. J Toxicology: Clin Toxicol. 1999;37(1):35\u201342.","journal-title":"J Toxicology: Clin Toxicol"},{"issue":"4","key":"2188_CR34","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1007\/BF03160931","volume":"3","author":"MA Miller","year":"2007","unstructured":"Miller MA, Navarro M, Bird SB, et al. Antiemetic use in acetaminophen poisoning: how does the route of N-acetylcysteine administration affect utilization? J Med Toxicol. 2007;3(4):152\u20136.","journal-title":"J Med Toxicol"},{"issue":"5","key":"2188_CR35","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1002\/pds.1940","volume":"19","author":"SeH Zyoud","year":"2010","unstructured":"Zyoud SeH, Awang R, Sulaiman SAS, et al. Association between gastrointestinal manifestations following acetaminophen poisoning and outcome in 291 acetaminophen poisoning patients. Pharmacoepidemiol Drug Saf. 2010;19(5):511\u20137.","journal-title":"Pharmacoepidemiol Drug Saf"}],"container-title":["BMC Medical Informatics and Decision Making"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12911-023-02188-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12911-023-02188-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12911-023-02188-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,14]],"date-time":"2023-12-14T14:45:31Z","timestamp":1702565131000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmedinformdecismak.biomedcentral.com\/articles\/10.1186\/s12911-023-02188-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,1]]},"references-count":35,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["2188"],"URL":"https:\/\/doi.org\/10.1186\/s12911-023-02188-2","relation":{},"ISSN":["1472-6947"],"issn-type":[{"value":"1472-6947","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,6,1]]},"assertion":[{"value":"16 March 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 May 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 June 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All methods were carried out in accordance with relevant guidelines and regulations. We obtained de-identified data from NPDS. This study was reviewed by Colorado Multiple Institutional Review Board on Human Subjects Protection and determined to be exempt (COMIRB#: 22-1088).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}},{"value":"Not Applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"AAPC supports the NPDS, which includes the data of all self-reporting patients collected by callers during poison information calls and exposure management by the country\u2019s PCCs. However, NPDS data do not reflect the total amount of exposure to a particular substance. Additional exposure to PCC can therefore be under-reported. Accordingly, NPDS data should not confirm poisoning or overdoses, and the AAPCC does not fully verify the accuracy of each report. Therefore, the results based on NPDS data do not necessarily reflect the AAPCC\u2019s opinion.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclaimers"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"102"}}